Back to Agenda
Adaptive Pathways and Conditional Approval – Panel Discussion
Session Chair(s)
Luca Pani, MD
Former, AIFA; Professor, Department of Psychiatry and Behavioral Sciences, University of Miami, United States
This panel will outline the possible opportunities from increasing documentation of real life and post approval data and the support provided by regulators to develop innovative drugs.
Speaker(s)
Hans-Georg Eichler, MD, MSc
Consulting Physician, Austrian Association of Social Security Bodies, Austria
Panel Discussion
Susan Forda, PhD
VP, GLobal Regulatory Affairs International, Eli Lilly & Company Ltd., United Kingdom
Panel Discussion
Niklas Hedberg, MPharm
HTACG Co-Chair & Chief Pharmacist, Dental and Pharmaceutical Benefits Agency, TLV, Sweden
Panel Discussion
François Houyez
Treatment Information and Access Director, Health Policy Advisor, European Organisation for Rare Diseases (EURORDIS), France
Panel Discussion
Tomas Salmonson, DrMed, PhD
, Critical Path Institute, Netherlands
Panel Discussion
Have an account?